Skip to main content
Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
8.76
-0.28 (-3.10%)
At close: Apr 1, 2025, 4:00 PM
9.14
+0.38 (4.34%)
After-hours: Apr 1, 2025, 6:21 PM EDT

Entrada Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
65.63-6.69-94.62-51.16-26.52
Upgrade
Depreciation & Amortization
3.772.841.91.120.33
Upgrade
Loss (Gain) From Sale of Assets
---0.070.02
Upgrade
Loss (Gain) From Sale of Investments
-10.02-5.780.15--
Upgrade
Stock-Based Compensation
17.9213.119.92.530.33
Upgrade
Change in Accounts Receivable
2.2-5.88---
Upgrade
Change in Accounts Payable
0.99-2.815.29-0.720.63
Upgrade
Change in Unearned Revenue
-119.81139.98---
Upgrade
Change in Income Taxes
-3.364.02---
Upgrade
Change in Other Net Operating Assets
1.121-16.4-2.71-0.35
Upgrade
Operating Cash Flow
-41.56139.8-93.79-50.86-25.57
Upgrade
Capital Expenditures
-3.16-5.61-2.89-4.58-2.32
Upgrade
Investment in Securities
-24.64-132.78-145.76--
Upgrade
Investing Cash Flow
-27.8-138.4-148.65-4.58-2.32
Upgrade
Issuance of Common Stock
102.9621.040.48191.630.25
Upgrade
Financing Cash Flow
102.9621.040.48307.4650.09
Upgrade
Net Cash Flow
33.6122.45-241.96252.0222.2
Upgrade
Free Cash Flow
-44.72134.19-96.67-55.44-27.89
Upgrade
Free Cash Flow Margin
-21.21%104.01%---
Upgrade
Free Cash Flow Per Share
-1.154.06-3.09-8.85-25.23
Upgrade
Cash Income Tax Paid
4.6214.72---
Upgrade
Levered Free Cash Flow
-73.29149.04-58.56-36.26-17.21
Upgrade
Unlevered Free Cash Flow
-73.29149.04-58.56-36.26-17.21
Upgrade
Change in Net Working Capital
121.2-140.686.683.37-1.13
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q